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right (RCA), 880 with leftanteriordescending (LAD) and 58 with circumflex
(Cx) coronary artery related myocardial infarcts (Ml). These studies were
analyzed for the presence and characteristics of MR and left ventricular (LV)
dilatation. The overall frequency of 22+ MR was 19% (17%-MD, 17%-RCA
and 24Y0-LCX).The degree of MR was distributed as follows: 2+ = 8Y0,3+ =
7%, 4+ =4%. MR was related to LVdilatation (p -=0.001). However, in mildly
dilated LV’S,the prevalence of MR was higher in RCA than in IAD infarcts
(Fig. 1).
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Toassess a possible mechanism of ischemic MR,a subset of 85 randomly
selected echocardiograms (53 RCAand 38 LAD)with ?2+ MRwere reviewed
to asseeejet eccentricity. In RCA Ml’s, 60% had eccentrically directed jets aa
compared to only 13% of those with LAD Ml’s (p < 0.001). This finding was
independent of LV size.
We conclude that 1) ischemic MR is common, 2) is equally distributed
among RCA, IAD and LCX Ml’s, and 3) is related to LVdilatation In LAD Ml’s
and probably related to papillary muscle dysfunction in RCA Ml’s,
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Hemi-Elliptic Curve-Fitting Algorithm: In-Vitro
Experiments With Native Nitral Valvee
J. Hopmeyer, S. He, K. Thorvig, E. McNeil, P.Wilkerson, R.A. Levine,
A.P.Yoganathan. Georgia Institute of Techno/og~Atlanta, GA, USA,
Massachusetts General Hospital, Boston, MA, USA
The flow convergence method was recently proposed for non-invasive quan-
tification of mitral regurgitation. Recent studies have demonstrated the limita-
tionsof the hemispheric (HS) assumption duetofinite regurgitant orifice size,
proximity of adjacent ventricular walls and presence of aortic outflow. The
hemi-elliptic (HE) modification has been proposed but has not been applied
clinically due to the difficulty in measuring the HE radius in three perpendicu-
Iarplanes. In this study, a curve-fitting algorithm was developed to extract the
HE dimensions from digitized color Doppler flow mapping (CDFM) images in
two standard views by rotating the transducer 90Q.Native mitral valves with
the entire apparatus presetved were implanted in an LV model to reproduce
the entire three-dimensional geometty while permitting close control and
measurement of experimental conditions. In-vitro pulsatile flow experiments
were conducted and mitral regurgitation was created by suturing the valve to
a larger annular ring to simulate annular dilation, producing 28 stages with
cardiac outputs from 1.5 to 6 Umin and peak regurgitant flow rates between 7
and 16 Umin. Results: Flow rate was calculated by the HE formula using the
curve fitting algorithm and compared to the HS formula. A plateau region was
obsewed in the HE data which approximated the true flow rate whereas no
such zone was evident forthe HS data. The HE formula accurately estimated
the true flow rate for all experimental condition (y= 1.02x + 0.29; r = 0.91;
Mean error = 0.5 A 1.17 L./rein). Conclusions: A curve-fitting algorithm was
developed to apply the HE formula to CDFM images in two perpendicular
planes comesxmding to apical views in patienta. This method accurately
estimates regurgitant flow rate in actual valve geometries and couldreadily
k automatedandincorporatedasa functionkeyonanultrasoundmachine.
D909109 A Clinical Investigation of the Importance ofimaging Slice Location in Quantifying Aottic
Regurgitation With MRI
G.P.Chatzimavroudis, J.N. Oshinski, R.H. French, R.1.Pettigrew,
P.G.Walker, A.P. Yoganathan. Georgia Institute of Techno/ogyAtlarrta, GA,
USA, Emory University Hospital, Atlanta, GA, USA
Our previous in vitro studies showed that imaging slice location in the aorta
is important for the accurate quantification of aortic regurgitation (AR) with
phase-velocity MRI. Errore from aorfic mmpliance (AC) and coronary flow
(CF) can be significant when the slice distance from the aortic valve is large.
The purpose of this study wastoevakmtethis information clinically. Methods:
15 patients with angiographically graded mild to severe AR were examined
in a 1.5 Tesia MRI scanner. Measurements of the regurgitant volume (RV)
were taken (Fig. 1): (1) between the valve and the coronary ostia; (2) at the
sinotubular junction (SJ); and (3)2 cm above the SJ.
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Resu/ts: Fig. 2 shows representative reeults from 3 patients, The mea-
sured RV decreased as the slice distance from the valve increased, due to
AC. This decrease was significant not only for mild AR cases, but for more
severe cases as well (30% decrease between slice locations 1 and 3 in
moderate-to-severeAR). The difference in the measured RV’Sbetween slice
locations 1 and 2 was generally smaller than that expected, This was due to
the CF effect. These in vivo results are in good agreement with the previous
in vitro results and confirm the importance of slice location, suggesting that
the RV be measured between the valve and the coronary ostia (slice location
1, Fig. 1) to achieve best diagnostic accuracy.
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~=[ Delayed BenefiCiaiEfferXa OfNitric OxicfeAgainst
Reperfusion Induced Coronary Endotheiial
Dysfunction in a Heterotopic Rat Heart
Trenspiantation Modei
G. Szab6, S. B?4hrle,S. BWai, T.J. Dengler, R. Zimmerman, C.F. Vahl,
S. Hagl. Unlversltyof Heidelberg, Heidelberg, Germany
Recently, we demonstrated a protective role of endogenous nitric oxide
(NO) In short time recovey from global hypothermic ischemia after heart
transplantation. In the present study, the effects of exogenous NO on short-
and long-term functional recovery from hypothermic ischemia and reper-
fusion was investigated in a heterotopic rat heart transplantation model,
After one hour ischemic preservation, reperfusion was started either af-
ter application of placebo (control, n = 8) or L-arginine (L-Arg, n = 8), a
substrate of NO-synthesis. Myacardial blood flow (MBF) was assessed by
the hydrogen-clearance method. An implanted balloon was used to obtain
pressure-volume relations of the transplanted heart Left ventricular pressure
(LVP), ikefirst derivative (dP/dt), end diastolic pressure (LVEDP), isovolumic
relaxation constant (T~) and MBF were measured after 80 minutes and 24
hours reperfusion. Endothelium dependent vasodilatation to acetylcholine
(ACH) and endothelium independent vasodilatation to sodium nitroprusside
(SNP) were also determimxt. After one hour, MBF was significantly higher
in the L-Arg group (3,6 + 0.6 vs. 2.0 + 0.2 ml/min/g, p < 0.05). The L-Arg
group showed abetter recovetyof systolic function and myocardial relaxation
(maximal LVP: 124+9 vs. 83+8 mmHg, p <0.05, maximal dP/dt: 5667
+ 498 vs. 3608 + 297 mmHg/s, p <0.05, TE: 9.9 + 1.0 vs. 15.7 + 1.4 ms,
p c 0.05 at an intraventricular volume of 80 Kl). LVEDP was similar in both
groups. After24 hours, there was no difference between the groups in basal
MBF, LVP,dP/dt, TE, LVEDP and the response of MBF to SNP. However,
ACH led to a significantly higher increase in MBF in the L-Arg group (52 +
13% vs. 29 + 7%, p < 0.05). These results indicate that 1) NO-donation
improves functional recovery during early reperfusion after hearf transplan-
tation, 2) NO also has a delayed beneficial effect against reperfusion induced
graft coronary endothelial dysfunction.
~91f)-1741 The Effect ofinhaiedNitric Oxide antflnhaled
Proategiandin El on Left Ventricular Contractility
in an Experimental Model of Pulmonary
Hypertension
P.Krieg, T. Wahlere, W. Giess, R. Rohde, M. Hartrumpf, M. Bund,
A. Haverich. Hannover UnhrerityMedicel School, HannoveC Germany
Pulmonay hypertension (PHT) isa lifethreatening complication after isolated
heart and lung transplantation. Recent work has shown that inhaled nitric
oxide (NO) in combination with inhaled prostaglandin EI (PGEt) reduce pui-
monary hypertension but their influence on cardiac contractility is less well
defined, This studv investigated left ventricular contractility as measured bvs. –. ., –.-
–.
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the “PreIoad Recruitable Stroke Work-Relation” (PRSW) in 24 anesthetized
open chest piga, 12 receiving in randomorder N050 ppm, PGEI 20 @ml and
their combination compared to 12controls. PHTwas induced by embolisation
with glasa beads (500#m). Prforto induction of PHTsonomicromatric crystals
were placed on the hearl to measure instantaneous cardiac dimensions. in-
stantaneous intraventricular pressure (micro-tip catheter) and intraventricular
dimensions were recorded digitally, while intraventricular volumes were cal-
culated from the intraventricular dimension applying the cylindric ellipsoidal
volume model for the left ventricle. PRSW was calculated from the instanta-
neous pressure and volume data during rapid vena caval occlusion by analy-
sis of generated pressure-volume Imps. All data were analyzed by MANOVA
and comectad for heart rate (level of significance #: p < 0.05; PRSW-slope
measures contractility, (PRSW-x-interceptdid not change significantly)
PRSW-change + SEM (% PHT)
NO vs. control PGEI VS. NO+ PGE1 V.%
#, p = 0.003 control control
PRSW: SIOP-S(verUM) –14.56*4.41 –8.77*4.59 -5.66*4.41
PRSW: slope (control) 1,63*4.48 0.98 *3.31 2.50&4.17
Appiioation of N050 ppm significantly reduced Ieftventricuiar contraofiiity
while PGEI 20 p~mi and the combination of NO 50 ppm and PGEI 20 @ml
did not. It is concluded that the combination of NO and PGEI forthetreatment
of puimonary hypertension should be considered for clinical application in
situations where a combination of pulmonaty hypertension and decreased
left ventricular function is present.
~0-1751 IS CO~OnaWStentinga~e~e~~Pti~ninP a,,,ative
Treatment of Cardiac Allograft Vasculopethy?
S.P.Jain, S. Zhang, S. Khosla, J.S. Jenkins, S.R. Ramee, M.R. Mehra,
H.O. Venture, D.D. Stapieton, N.E. McCaffhY,T.J. Coiiins. Ochsnerclinic,
New Orfeans, LA, USA
Elective coronary stenting is associated with excellent acute success, re-
duced restenosis rate and improved late clinical outcome in native coronaiy
atherosclerotic disease. However, its efficacy inpatients with cardiac aiiograft
vasculopathy (CAV) is not known. From 3/94 to &’96, ten pts (13 lesions) with
CAV underwent coronay stenting using Paimaz-Schatz stents (average size
3.4 mm, totai number = 14). The indications for PTCA were post Ml angina
(n= 2), unstable angina (n= 4), stabie angina (n = 3) and congestive hearl
faiiure (n = 1). The indication for stenting were e.uboptimal results (n = 3)
and eiecfive in (n = 10). The arteries stentad included LM = 1, LAD= 4, LCX
=2 and RCA =4. High pressure balloon dilatations were performed foilowing
initial stent deployment (mean atm 14). All pts were treatad with Aspirin 325
mg and Ticlopidine 500 m~day except 2 pts who received a combination of
Aspirin, Persantine, and Coumadin. Qualitative angiography was performed
using a automated edge detection technique (Arfrek). Procedural success
(< 30% residual diameter stenosis without Q wave Ml or death), in-hospital
implications and 6 months outcome were anaiyzed.
Results:
Pre Post
MinimalLuminslDiameter (mm) 0.63+0.28 3.40+ 0.56
Diamet6rstenosis (%) 42.5& 7.8 5.3*5.2
Acute Gain (mm) 2.60+ 0.6
Procedural success was achieved in all pts. There were no stent throm-
bosis, Q or non Q wave Mi, vascular complications or death prior to the
diecharge. Foilow-up angiography at six month was available in 7/10 pts and
none required target lesion revascularization.
Cone/us/ens:Coronary etenting in pts with CAV can be performed safeiy
with exeiient angiographic success and favorable iong-term results.
m910176 Naturally Occuring Leukopeniaas a Marker forGood Outcome After Cardiac Transplantation
J.A. Kobashigawa, G.A. Cogert, A. Sabad, H. Muhimeister, J.D. Cassem,
J. Moriguchi, N. Kawate, M.A. Hamiiton, A. Hage, D. Drfnkwater,H. Leks.
The University of California at Los Angel@s,Los Angelea, CA, USA
The mechanisms of graft toierancs are not well understood. It appears that
an immune suppression mechanism is responsible for this prooesa. in review
of 472 haarl transplant patients between 1984 and 1994, we have notad an
improved outcome for patients with naturally occurring Ieukopenia (WBC <
4000) more than 6 months after tranpelant deepite being discontinued from
ezathioprine and not having concomitant viral syndromea (cytomegalovirus)
or other extrineic WBC lowering causes. 14 patients with Ieukopenia (Group
A) were compared with 456 patients without Ieukopenia (Group B). Five year
aotuariai survival was 92~o in Group Avereus 69% in Group B (p < 0.05) (see
table). Similarly, 5 year freedom from transplant corona~ artery disease waa
greater in Group A versus Group B (85% versus 61%, respectively, p < 0.05).
First year rejection and infection incidence and demographic characteristics
inciuding recipiant and donor age, percent female, ischemic time, number
HLA mismatches, were not different between the two groups. All patientS
were initiaily treated with cyciosponne A based immunosuppression.
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Corrc/usion: Naturally occurring Ieukopenia in heart transplant patients
more than 6 months after transplant appears to be associat~ with graft
toierance by improved graft survival and freedom from transplant coronary
artery disease. Further investigation into the cause of this Ieukopenia is
warranted.
1910-1771 Management of Ischemiclieartt)isee.s ein
Patiants Referred for Cardiac Transplantation
C. Yancy,J. Escobar, M. Solomon, D. Meyer, S. Ring. UT Southwestern
Medical Center/St. Paul Medical Centec Dallas, TX, USA
Cardiac transplantation (CT) vs medical therapy (MT) or bypass grafting
(CABG) isdifficuittotriage inpts with ischemic heart disease (IHD). Question:
Does evidence of ischemia facilitate the decision of CT vs MT or CABG?
Methods: 79 pts (70 M, 9 F, age 53.7) referred for CT, with evidence of IHD,
(47% CABG, 53% e/p Mi), had V02 max, PCWP,and LVEF meaaurad. 49i79
had perfusion imaging study (SCAN). 30iT9 had active angina, (+) ETT, or
were too sick for assessment. Iechemia (iSCH) was defined as angina, (+)
SCAN, or (+) ETT. CABG was offered for suitabie anatomy and (+) ISCH;
MT was offered for pts with VOA >15 and (–) ISCH or unsuitable anatomy
for CABG; and CT was offered for pts with VOA <15. Endpoint was eurvival
at 1 year. Results:
MorWlity* LVEF V02 PCWP (+) SCAN (+) ISCH
MT (n =26) 7.7% 0.24 20 21 7/21 6/26
CASG (n = 12) 6.3”h 0.28 21 19 S1 6 12/12
CT (n = 31) 6.1”/0 o.17t 13t Zgt 4/14 5/31
WaitingCT (n = 10) 70%- O.lgt ,~t ~~t ze 4/10
Deaths (n= 10) - 0.20* 1st Zgt 416 6/10
*P= NSforMTVS CASG vs CT; **P < O.O5;tp <0.001 for CT or Death vs CABG or MT
/rnp: After adjusting for CABG, (+) SCAN or (+) ISCH did not predict
mortaiify. VOA mex was more predictive of outcome by multiple regression
anaiysis. Conclusion: Appropriate triage to MT/CABG ve CT can be best
done for pts with IHD based on measures of VOZ/PCWP and LVEF.
D910178 Heart Transplantation in Canada andDeterminants of Early and Late Mortality
R.A. Davies, M. Rivard, P.W.Pflugfelder, B. Jolain. University of Otfawa
Heart institute, Ottawa, Ontario, Canada, Canadian Heart Transplant
Centers, Canada
A muiticenter retrospective longitudinal study of patients who underwent first
adult heart transplant in Canada, since the introduction of cyclosporine, was
,conduotedin all ten centers. Between April 1961 and December 1992, 1083
patients underwent transplant. The role of 65 covariates on early (<90 day)
and iate mortality was assessed.
Mean age (+ SD) was 47 + 11 years (15-69 with 26% 55+. Diagnosis
was CAD in 49% (of whom 42% had CABG) and cardiomyopathy in 39%.
Mean donor age was 33 & 11years (10-63) with 13Y045+. Treated rejection
occurred in 72% of patients. Cholesterol rose from 176 + 58 mg/dl preop to
248 + 5S mg/dl one year postop.
Death occurred in 302 patients (159 early) and 19 ware retransplantad.
Causes of early death were perioperative graft failure 28%, rejection 23%,
infection 17%,CAD4% and other 28Y0.Late death was due to rejection 30%,
CAD 21%, infection 13%, cancer 8% and other 26%. Kaplan-Meier aurvival
rates at 1 and 5 years were 60Y. and 88Y0.
Univariate analysis of selectad variables among both earfy and late aur-
vivors showad increased mortality with both older donors (p < 0.0C05) and
female donore (p = 0.002, Tarone-Ware weighted Iogrank atatiatios). How-
ever female donors were older (Pearson Chi-square, p c 0.0005). Of donors
aged 45+ yeare, 21% were femaie and 10% were male.
Muitivariate anaiyeis of patients who survived more than 90 days showad
that older donor age (p < 0.0001), but not female gender, predicted increased
